EyeCare Services Partners ("ESP") - Buyer Spotlight
EyeCare Services Partners was founded in 2014 with Varsity Healthcare Partners acquisition of Lutherville, MD-based Katzen Eye Group. We consider ESP one of the first investments in this wave, and view Varsity Healthcare Partners as a leader and early mover in physician practice management. It is often one of the first firms to enter a new specialty.
ESP was recapitalized to a new investor, Harvest Partners, in 2017. Harvest is also a leader in physician practice management and is active in many healthcare verticals.
EyeCare Services Partners has completed more ophthalmology deals than any other investor, based on our internal tracking. We count 24 ophthalmology deals, though ESP was the most active in 2017 and 2018. We expect accelerated acquisitions in 2021 and beyond.
EyeCare Services Partners has one of the largest geographic footprints among ophthalmology buyers and owns practices in the following markets -
Chicago, Illinois area
Washington, DC/Maryland area
Parts of Southern California
Denver, Colorado area
Howard Jacobson, MD; Washington, DC
Eye Surgery Associates; Hollywood, FL
Delray Eye Associates; Delray Beach, FL
Chicago Eye Consultants; Stickney, IL
Katzen Eye Care and Laser Center; Palm Beach, FL
Mid Florida Eye Center; Mount Dora, FL
Retina Group Chicago; Hinsdale, IL
Smith-Perry Eye Center; Chicago, IL
National Retina Institute; Washington, DC
Yavitz Eye Center; Chicago, IL
Midwest Eye Center; Chicago, IL
Florida Vision Institute; West Palm Beach, FL
Eye Doctors of Washington; Washington, DC
Lakeside Eye Group; Chicago, IL
Delaware Eye Institute; Rehoboth Beach, DE
Shasta Eye Medical Group; Redding, CA
Hauser-Ross Eye Institute; Chicago, IL
Chicagoland Retinal Consultants; Chicago, IL
Milauskas Eye Institute; La Quinta, CA
Inland Eye Specialists; Hemet, CA
Spivack Vision Center; Denver, CO
Omni Eye Specialists; Denver, CO
Delaware EyeCare Center; Bear, DE
Katzen Eye Group; Lutherville, MD
To learn more, download our latest ophthalmology industry report entitled ...
"After a Strong First Quarter, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals"
This post is for informational purposes only and does not constitute an offer, invitation, solicitation, or recommendation to buy, sell, subscribe for, or issue any securities. While the information provided herein is believed to be accurate and reliable, 127 Capital, LLC (“Physicians First”) makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.